These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 33846863)

  • 1. Choice and switch of biologic drugs in juvenile idiopathic arthritis.
    Şener S; Başaran Ö; Batu ED; Cüceoğlu MK; Balık Z; Aliyev E; Bayındır Y; Bilginer Y; Özen S
    Turk J Pediatr; 2023; 65(6):980-989. PubMed ID: 38204313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.
    Kearsley-Fleet L; Davies R; Baildam E; Beresford MW; Foster HE; Southwood TR; Thomson W; Hyrich KL
    Rheumatology (Oxford); 2016 Sep; 55(9):1556-65. PubMed ID: 26732349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease control and health-related quality of life in juvenile idiopathic arthritis.
    Seid M; Opipari L; Huang B; Brunner HI; Lovell DJ
    Arthritis Rheum; 2009 Mar; 61(3):393-9. PubMed ID: 19248113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying factors associated with substantially reduced adult height in patients with juvenile idiopathic arthritis: a retrospective cohort study.
    Chen HY; Hu YC; Yang YH; Chiang BL
    BMC Pediatr; 2024 May; 24(1):375. PubMed ID: 38816849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity assessment for juvenile idiopathic arthritis in transitional care.
    La Torre F; Coppola C; Anelli MG; Cacciapaglia F; Lopalco G; Cardinale F; Iannone F
    Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis.
    Choida V; Hall-Craggs M; Jebson BR; Fisher C; Leandro M; Wedderburn LR; Ciurtin C
    Front Pharmacol; 2020; 11():635823. PubMed ID: 33603671
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis.
    Wedderburn LR; Ramanan AV; Croft AP; Hyrich KL; Dick AD;
    Ann Rheum Dis; 2023 Apr; 82(4):449-456. PubMed ID: 36600186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges Nurses Face in Providing Care for Patients with Juvenile Idiopathic Arthritis.
    Fusama M; Nakahara H; Miyamae T; Mori M; Urata Y; Kawahata K; Kawahito Y; Kojima M; Sugihara T; Hashimoto M; Murashima A; Yajima N; Matsui T
    Mod Rheumatol; 2024 May; ():. PubMed ID: 38722031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedically Relevant Applications of Bolaamphiphiles and Bolaamphiphile-Containing Materials.
    Hughes JR; Miller AS; Wallace CE; Vemuri GN; Iovine PM
    Front Chem; 2020; 8():604151. PubMed ID: 33553103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    K Akca Ü; Batu ED; Kısaarslan AP; Poyrazoğlu H; Ayaz NA; Sözeri B; Sağ E; Atalay E; Demir S; Karadağ ŞG; Demir F; Bilginer Y; Gümrük F; Özen S
    Lupus; 2021 Sep; 30(10):NP1-NP8. PubMed ID: 33951967
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
    Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
    Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to collaborate: Objectives, design, and methodology of PeRA-Research Group.
    Sozeri B; Emine Sonmez H; Demir F; Cakan M; Ozturk K; Ozdel S; Otar Yener G; Gul Karadag S; Aktay Ayaz N
    North Clin Istanb; 2021; 8(2):200-202. PubMed ID: 33851091
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study.
    Grazziotin LR; Currie G; Twilt M; Ijzerman MJ; Kip MMA; Koffijberg H; Benseler SM; Swart JF; Vastert SJ; Wulffraat NM; Yeung RSM; Marshall DA
    Pediatr Rheumatol Online J; 2022 Apr; 20(1):25. PubMed ID: 35410419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to switching biologics in juvenile idiopathic arthritis: a real-life experience.
    Karadağ ŞG; Demirkan FG; Koç R; Çakmak F; Sönmez HE; Aktay Ayaz N
    Rheumatol Int; 2022 Jan; 42(1):141-147. PubMed ID: 33846863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.
    Ayaz NA; Karadağ ŞG; Koç R; Demirkan FG; Çakmak F; Sönmez HE
    Rheumatol Int; 2020 Jul; 40(7):1111-1116. PubMed ID: 32417938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience.
    Demir S; Sönmez HE; Arslanoğlu-Aydın E; Özen S; Bilginer Y
    Turk J Pediatr; 2019; 61(2):180-185. PubMed ID: 31951328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review.
    Davies R; Gaynor D; Hyrich KL; Pain CE
    Semin Arthritis Rheum; 2017 Apr; 46(5):584-593. PubMed ID: 27914689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Judicious use of biologicals in juvenile idiopathic arthritis.
    Zhao Y; Wallace C
    Curr Rheumatol Rep; 2014 Nov; 16(11):454. PubMed ID: 25218736
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.